FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > FSD Pharma updates recent

<< Previous

Bullboard Posts

Next >>

Comment by Mil_Man54on Feb 03, 2023 12:31pm

48 Views

Post# 35265165

RE:RE:RE:RE:RE:FSD Pharma updates recent

You seemed to have changed the subject Rosenberg.....I said they did not have enough funds to complete even one trial and you wanted proof....which I provided.....now you're on about how their salaries are justified....which is BS BTW.....so how about you get back on topic and tell us how they're going to complete the trials after they run out of cash.....

DavidRosenberg wrote:

Mil_Man54 wrote: Talk is cheap Rosenberg...but the financials speak for themselves.....take a look at the last financial statement dated Nov 11, 2022.....

9 months ending 30 Sep 22
Salaries, benefits, bonuses and consulting fees                   1,390,070
Share-based payments and bonuses                                      828,664
                                                                                              2,218,734

Total operating expenses                                                     20,769,836

How much cash on hand Rosenberg....$40M or so.....no cash coming in....unsustainable expenses.....so you tell us how they'll have enough funds to finish a trial that will take years if not a decade?

DavidRosenberg wrote:

Mil_Man54 wrote: And they don't have enough money to complete even one trial!

talk is cheap , show proof to me that they don't have enough money to start trials

their financials showed they have money to start all 3 trials

they also sold the cannabis facility for gains so your comments are misleading milman not mine

https://www.businesswire.com/news/home/20220510005660/en/FSD-Pharma-Closes-CAD16.4-Million-Sale-of-Non-Core-Assets

nobody works for free

as long as milestones are reached and positive reflection on stock price and shareholder value is grown then I don't care as long as it's reasonable amounts

if it's $10,000,000 self serving package then it would be a red flag those rates and crazy

if it's within range of average corporate expenditure then I'm ok with it as long as they do what they say

and they have reached those milestones

options are restricted , so it Is what it is and another green day

let's hope good results from clinical trials showing efficacy